Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 1/20 | 0.56 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.56 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.55 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 3/20 | 0.54 |
| ▸ | RAB9A | P51151 | 3/20 | 0.54 |
| ▸ | TP53 | P04637 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | GAA | P10253 | 3/20 | 0.51 |
| ▸ | APP | P05067 | 1/20 | 0.51 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.51 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.50 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.50 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.50 |
| ▸ | ALPL | P05186 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nicotinyl Methylamide SCHEMBL30664356 | 0.88 | HDAC1 (0.69) | HDAC1HDAC6MKNK1MKNK2LMNA | |
| Nicotinyl Methylamide SCHEMBL28560459 | 0.88 | HDAC1 (0.69) | HDAC1HDAC6MKNK1MKNK2LMNA | |
| Nicotinyl Methylamide SCHEMBL129458 | 0.88 | HDAC1 (0.69) | HDAC1HDAC6MKNK1MKNK2LMNA | |
| Nicotinyl Methylamide SCHEMBL5528294 | 0.87 | HDAC1 (0.67) | HDAC1HDAC6MKNK1MKNK2LMNA | |
| Nicotinyl Methylamide SCHEMBL22190418 | 0.87 | HDAC1 (0.67) | HDAC1HDAC6MKNK1MKNK2LMNA | |
| Nicotinyl Methylamide SCHEMBL4730618 | 0.87 | HDAC1 (0.67) | HDAC1HDAC6MKNK1MKNK2LMNA | |
| Nicotinyl Methylamide SCHEMBL9275531 | 0.87 | HDAC1 (0.67) | HDAC1HDAC6MKNK1MKNK2LMNA | |
| Nicotinyl Methylamide SCHEMBL22190415 | 0.87 | HDAC1 (0.67) | HDAC1HDAC6MKNK1MKNK2LMNA | |
| Nicotinyl Methylamide SCHEMBL29082835 | 0.87 | HDAC1 (0.67) | HDAC1HDAC6MKNK1MKNK2LMNA | |
| Nicotinyl Methylamide SCHEMBL5891238 | 0.87 | HDAC1 (0.67) | HDAC1HDAC6MKNK1MKNK2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110023752-B | Diagnosis, prognosis and treatment of schizophrenia and schizoaffective disorders | 精密医药控股私人有限公司 | 2021-06-29 | — | — | CN | disclosed |
| US-20200049722-A1 | DIAGNOSIS, PROGNOSIS AND TREATMENT FOR SCHIZOPHRENIA AND SCHIZOAFFECTIVE PSYCHOSIS | PRECISION MEDICINE HOLDINGS PTY LTD (AU) | 2020-02-13 | — | — | US | disclosed |
| US-20160349274-A1 | MENTAL ILLNESS MODEL AND MENTAL ILLNESS RISK ASSESSMENT TEST FOR SCHIZOPHRENIC PSYCHOSIS | WILLIAMS STEPHANIE SUE (AU) | 2016-12-01 | — | — | US | disclosed |
| US-20140113318-A1 | Novel Biomarkers | FRYAR-WILLIAMS, STEPHANIE (AU) | 2014-04-24 | — | — | US | disclosed |
| US-20120094315-A1 | BIOMARKERS FOR THE DIAGNOSIS AND/OR PREDICTION OF SUSCEPTIBILITY TO MENTAL AND NEURODEGENERATIVE DISORDERS | FRYAR-WILLIAMS STEPHANIE (AU) | 2012-04-19 | — | — | US | disclosed |